메뉴 건너뛰기




Volumn 20, Issue 5, 2018, Pages 908-909

Fixed-dose combinations: A valuable tool to improve adherence to antihypertensive treatment

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN INHIBITOR; ANTIHYPERTENSIVE AGENT;

EID: 85046033961     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.13299     Document Type: Note
Times cited : (4)

References (22)
  • 1
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903‐1913.
    • (2002) Lancet , vol.360 , pp. 1903
    • Lewington, S.1    Clarke, R.2    Qizilbash, N.3    Peto, R.4    Collins, R.5
  • 2
    • 77955014011 scopus 로고    scopus 로고
    • Risk factors for ischaemic and in-tracerebral haemorrhagic stroke in 22 countries (The INTERSTROKE study): A case-control study
    • O’Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and in-tracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376:112‐123.
    • (2010) Lancet , vol.376 , pp. 112-123
    • O’Donnell, M.J.1    Xavier, D.2    Liu, L.3
  • 3
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (The INTERHEART study): Case-control study
    • Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937‐952.
    • (2004) Lancet , vol.364 , pp. 937
    • Yusuf, S.1    Hawken, S.2    Ounpuu, S.3
  • 4
    • 67650082354 scopus 로고    scopus 로고
    • Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
    • (2009) BMJ , vol.338 , pp. 1665
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 5
    • 77952750659 scopus 로고    scopus 로고
    • US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008
    • Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043‐2050.
    • (2010) JAMA , vol.303 , pp. 2043
    • Egan, B.M.1    Zhao, Y.2    Axon, R.N.3
  • 6
    • 79958759601 scopus 로고    scopus 로고
    • Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades
    • McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011;183:1007‐1013.
    • (2011) CMAJ , vol.183 , pp. 1007
    • McAlister, F.A.1    Wilkins, K.2    Joffres, M.3
  • 7
    • 84981250226 scopus 로고    scopus 로고
    • Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries
    • Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441‐450.
    • (2016) Circulation , vol.134 , pp. 441
    • Mills, K.T.1    Bundy, J.D.2    Kelly, T.N.3
  • 8
    • 84978651932 scopus 로고    scopus 로고
    • Trends in antihypertensive medication discontinuation and low adherence among Medicare beneficiaries initiating treatment from 2007 to 2012
    • Tajeu GS, Kent ST, Kronish IM, et al. Trends in antihypertensive medication discontinuation and low adherence among Medicare beneficiaries initiating treatment from 2007 to 2012. Hypertension. 2016;68:565‐575.
    • (2016) Hypertension , vol.68 , pp. 565
    • Tajeu, G.S.1    Kent, S.T.2    Kronish, I.M.3
  • 10
    • 84958051638 scopus 로고    scopus 로고
    • Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications
    • Kim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016;67:506‐512.
    • (2016) Hypertension , vol.67 , pp. 506
    • Kim, S.1    Shin, D.W.2    Yun, J.M.3
  • 11
    • 84922391679 scopus 로고    scopus 로고
    • Association of medical treatment nonadherence with all-cause mortality in newly treated hy-pertensive US veterans
    • Gosmanova EO, Lu JL, Streja E, et al. Association of medical treatment nonadherence with all-cause mortality in newly treated hy-pertensive US veterans. Hypertension. 2014;64:951‐957.
    • (2014) Hypertension , vol.64 , pp. 951
    • Gosmanova, E.O.1    Lu, J.L.2    Streja, E.3
  • 12
    • 85019880651 scopus 로고    scopus 로고
    • Risk factors for nonadherence to antihypertensive treatment
    • Gupta P, Patel P, Štrauch B, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017a;69:1113‐1120.
    • (2017) Hypertension , vol.69 , pp. 1113
    • Gupta, P.1    Patel, P.2    Štrauch, B.3
  • 14
    • 84884685620 scopus 로고    scopus 로고
    • Prevalence of resistant hypertension in 1810 patients followed up in a specialized outpatient clinic and its association with the metabolic syndrome
    • Tziomalos K, Kirkineska L, Baltatzi M, et al. Prevalence of resistant hypertension in 1810 patients followed up in a specialized outpatient clinic and its association with the metabolic syndrome. Blood Press. 2013;22:307‐311.
    • (2013) Blood Press , vol.22 , pp. 307
    • Tziomalos, K.1    Kirkineska, L.2    Baltatzi, M.3
  • 15
    • 85051996849 scopus 로고    scopus 로고
    • The impact of fixed dose combination versus free-equivalent combination therapies on adherence for hypertension: A meta-analysis
    • Du LP, Cheng ZW, Zhang YX, Li Y, Mei D. The impact of fixed dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. J Clin Hypertens (Greenwich). 2018. https://doi.org/10.1111/jch.13272.
    • (2018) J Clin Hypertens (Greenwich)
    • Du, L.P.1    Cheng, Z.W.2    Zhang, Y.X.3    Li, Y.4    Mei, D.5
  • 16
    • 83155192207 scopus 로고    scopus 로고
    • Predictors of decline in medication adherence: Results from the cohort study of medication adherence among older adults
    • Krousel-Wood M, Joyce C, Holt E, et al. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension. 2011;58: 804‐810.
    • (2011) Hypertension , vol.58 , pp. 804
    • Krousel-Wood, M.1    Joyce, C.2    Holt, E.3
  • 17
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417‐2428.
    • (2008) N Engl J Med , vol.359 , pp. 2417
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 18
    • 84902275601 scopus 로고    scopus 로고
    • Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs
    • Wang TD, Chen YH, Huang CH, Chen WJ, Chen MF. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs. Hypertension. 2014;63:958‐967.
    • (2014) Hypertension , vol.63 , pp. 958
    • Wang, T.D.1    Chen, Y.H.2    Huang, C.H.3    Chen, W.J.4    Chen, M.F.5
  • 19
    • 84988530852 scopus 로고    scopus 로고
    • Achieving adherence after first-line antihypertensive treatment: Should fixed-dose combinations receive priority?
    • Sonawane Deshmukh KB, Qian J, Garza KB, et al. Achieving adherence after first-line antihypertensive treatment: should fixed-dose combinations receive priority? J Clin Hypertens (Greenwich). 2016;18:934‐941.
    • (2016) J Clin Hypertens (Greenwich) , vol.18 , pp. 934
    • Sonawane Deshmukh, K.B.1    Qian, J.2    Garza, K.B.3
  • 20
    • 85041582194 scopus 로고    scopus 로고
    • Use of strategies to improve antihypertensive medication adherence within United States outpatient health care practices, DocStyles 2015-2016
    • Chang TE, Ritchey MD, Ayala C, Durthaler JM, Loustalot F. Use of strategies to improve antihypertensive medication adherence within United States outpatient health care practices, DocStyles 2015-2016. J Clin Hypertens (Greenwich). 2018;20:225‐232.
    • (2018) J Clin Hypertens (Greenwich) , vol.20 , pp. 225
    • Chang, T.E.1    Ritchey, M.D.2    Ayala, C.3    Durthaler, J.M.4    Loustalot, F.5
  • 21
    • 85030165835 scopus 로고    scopus 로고
    • Mobile phone text messaging improves antihypertensive drug adherence in the community
    • Varleta P, Acevedo M, Akel C, et al. Mobile phone text messaging improves antihypertensive drug adherence in the community. J Clin Hypertens (Greenwich). 2017;19:1276‐1284.
    • (2017) J Clin Hypertens (Greenwich) , vol.19 , pp. 1276
    • Varleta, P.1    Acevedo, M.2    Akel, C.3
  • 22
    • 85031807726 scopus 로고    scopus 로고
    • Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence
    • Gupta P, Patel P, Štrauch B, et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017b;70:1042‐1048.
    • (2017) Hypertension , vol.70 , pp. 1042
    • Gupta, P.1    Patel, P.2    Štrauch, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.